The Recent Patents On Endocrine, Metabolic And Immune Drug Discovery is a research journal published by the Bentham Science Publishers. The P-ISSN of this journal is 18722148.
Also, please check the following important details about recent patents on endocrine, metabolic and immune drug discovery: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.
According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.
Journal Title: | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery |
Publisher: | Bentham Science Publishers |
P-ISSN: | 18722148 |
Open Access: | |
Status: | Inactive |
Scopus Coverage: | 2008-2017 |
The recent patents on endocrine, metabolic and immune drug discovery is indexed in:
An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.
The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).
The publication time may vary depending on factors such as the complexity of the research and the current workload of the editorial team. Journals typically request reviewers to submit their reviews within 3-4 weeks. However, some journals lack mechanisms to enforce this deadline, making it difficult to predict the duration of the peer review process.
The review time also depends upon the quality of the research paper.
Visit to the official website of the journal/ conference to check the details about call for papers.
If your research is related to the scope of the journal, then visit the official website of recent patents on endocrine, metabolic and immune drug discovery and send your manuscript.